IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PECORELLI, Sergio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.601
AS - Asia 5.639
EU - Europa 4.694
SA - Sud America 1.059
AF - Africa 117
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 14
AN - Antartide 1
Totale 27.142
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.364
CN - Cina 2.163
SG - Singapore 1.739
UA - Ucraina 1.313
BR - Brasile 862
IT - Italia 680
DE - Germania 635
HK - Hong Kong 579
PL - Polonia 428
FI - Finlandia 427
VN - Vietnam 335
FR - Francia 295
GB - Regno Unito 256
TR - Turchia 209
IN - India 203
IE - Irlanda 196
RU - Federazione Russa 182
CA - Canada 160
BD - Bangladesh 101
SE - Svezia 77
AR - Argentina 68
IQ - Iraq 52
MX - Messico 45
JP - Giappone 37
NL - Olanda 36
ZA - Sudafrica 35
ID - Indonesia 34
EC - Ecuador 32
ES - Italia 32
VE - Venezuela 30
SA - Arabia Saudita 25
EE - Estonia 24
BE - Belgio 23
AT - Austria 19
MU - Mauritius 19
LT - Lituania 18
PK - Pakistan 18
MA - Marocco 17
CL - Cile 16
CO - Colombia 16
EU - Europa 16
AE - Emirati Arabi Uniti 15
AU - Australia 13
PY - Paraguay 13
UZ - Uzbekistan 13
IR - Iran 12
CZ - Repubblica Ceca 11
NP - Nepal 11
UY - Uruguay 11
IL - Israele 9
KG - Kirghizistan 9
TN - Tunisia 9
AZ - Azerbaigian 8
JM - Giamaica 8
KE - Kenya 8
KZ - Kazakistan 8
NG - Nigeria 8
CH - Svizzera 7
JO - Giordania 7
KR - Corea 7
TW - Taiwan 7
EG - Egitto 6
PE - Perù 6
PT - Portogallo 6
CR - Costa Rica 5
DZ - Algeria 5
AL - Albania 4
BH - Bahrain 4
BO - Bolivia 4
LK - Sri Lanka 4
LV - Lettonia 4
MY - Malesia 4
OM - Oman 4
PS - Palestinian Territory 4
RO - Romania 4
TH - Thailandia 4
BB - Barbados 3
BG - Bulgaria 3
GE - Georgia 3
GR - Grecia 3
LU - Lussemburgo 3
PH - Filippine 3
BM - Bermuda 2
BS - Bahamas 2
BY - Bielorussia 2
ET - Etiopia 2
GA - Gabon 2
LB - Libano 2
PR - Porto Rico 2
AG - Antigua e Barbuda 1
AO - Angola 1
AQ - Antartide 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GT - Guatemala 1
GY - Guiana 1
Totale 27.121
Salva come PNG Salva come JPEG
Città #
Fairfield 1.663
Woodbridge 1.636
Ashburn 1.485
Houston 1.149
Singapore 941
Jacksonville 920
Ann Arbor 800
Wilmington 764
Seattle 708
Cambridge 646
Hong Kong 557
San Jose 439
Warsaw 421
Beijing 389
New York 369
Chandler 365
Nanjing 354
Princeton 353
The Dalles 302
Los Angeles 297
Dearborn 212
Helsinki 212
Dublin 196
Istanbul 163
Lauterbourg 155
Dallas 153
Nanchang 128
Ho Chi Minh City 126
Des Moines 117
Moscow 100
San Francisco 97
San Diego 90
Shenyang 87
São Paulo 83
Chicago 81
Changsha 76
Milan 73
Orem 73
Munich 72
Buffalo 71
Shanghai 70
Hebei 67
Kunming 67
Santa Clara 64
Hanoi 63
Denver 62
Jinan 60
Jiaxing 59
Toronto 59
Redondo Beach 58
Tianjin 55
London 52
Brescia 50
Hangzhou 45
Montreal 41
Brooklyn 39
Atlanta 35
Phoenix 34
Chennai 31
Verona 31
Indianapolis 30
Tokyo 29
Turku 29
Rome 28
Zhengzhou 28
Ningbo 25
Rio de Janeiro 25
Tallinn 24
Nuremberg 23
Belo Horizonte 22
Boston 22
Hefei 22
Charlotte 21
Brasília 20
Lancaster 20
Lanzhou 20
Monmouth Junction 20
Stockholm 20
Brussels 19
Council Bluffs 19
Guangzhou 19
Washington 19
Mumbai 18
Taizhou 18
Amsterdam 17
Mexico City 17
Orange 17
Poplar 17
Porto Alegre 17
Pune 17
Baghdad 16
Dong Ket 16
Frankfurt am Main 16
Johannesburg 16
Norwalk 16
Central 14
Dhaka 14
Manchester 14
Miami 14
Paris 14
Totale 18.757
Salva come PNG Salva come JPEG
Nome #
Cancer-related anemia: pathogenesis, prevalence and treatment. 1.204
Bambini pretermine: nati per vivere 364
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 361
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 331
Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection in adolescents in Northern Italy: an observational school-based study. 314
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 286
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor 236
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. 224
OVEREXPRESSION OF CLOSTRIDIUM PERFRINGENS ENTEROTOXIN RECEPTORS CLAUDIN-3 AND CLAUDIN-4 IN UTERINE CARCINOSARCOMAS. 222
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 219
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 210
An Integrated Approach for a Structural and Functional Evaluation of Biosimilars: Implications for Erythropoietin 206
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 204
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 204
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 202
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 202
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes 196
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas 191
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 190
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). 188
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 186
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody. 185
Effect of transdermal estradiol and oral conjugated estrogen on C-reactive protein in retinoid-placebo trial in healthy women 184
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. 183
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 182
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 177
DEVELOPMENT AND THERAPEUTIC EFFECT OF ADOPTIVELY TRANSFERRED T CELLS PRIMED BY TUMOR LYSATE-PULSED AUTOLOGOUS DENDRITIC CELLS IN A PATIENT WITH METASTATIC ENDOMETRIAL CANCER. 176
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas. 176
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 176
Abridged republication of FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum 176
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 174
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 173
Overexpression of mammaglobin B in epithelial ovarian carcinomas. 172
Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency 170
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 169
Chlamydia trachomatis genotypes in school adolescents, Italy 168
Consolidation therapies revisited: weekly paclitaxel 168
Mammaglobin B expression in human endometrial cancer 167
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). 166
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 166
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody 166
Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumab. 165
Carcinoma of the Fallopian tube 164
Strategies to Improve Medication Adherence in Older Persons: Consensus Statement from the Senior Italia Federanziani Advisory Board 164
ADVANCES IN DENDRITIC-CELL-BASED THERAPEUTIC VACCINES FOR CERVICAL CANCER. 162
Racial differences in overexpression of epidermal growth factor type II receptor (HER2/neu): a major prognostic indicator in Uterine Serous Papillary Cancer 161
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody 161
TUMOR-INFILTRATING LYMPHOCYTES CONTAIN HIGHER NUMBERS OF TYPE 1 CYTOKINE EXPRESSORS AND DR+ T CELLS COMPARED WITH LYMPHOCYTES FROM TUMOR DRAINING LYMPH NODES AND PERIPHERAL BLOOD IN PATIENTS WITH CANCER OF THE UTERINE CERVIX. 159
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor 159
Toward appropriate criteria in medication adherence assessment in older persons: Position Paper 158
Computational and functional analysis of biopharmaceutical drugs in zebrafish: Erythropoietin as a test model 158
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities. 156
Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference 156
Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin. 154
Early stage cervical cancer: adjuvant treatment in negative lymph node cases. 154
Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium. 154
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 153
Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer 152
Carcinoma of the corpus uteri 152
Carcinoma of the Fallopian tube 150
HPV vaccination acceptability in young boys 149
Prescription drug use among older adults in Italy: A country-wide perspective 149
Prognostic Significance of Vascular Endothelial Growth Factor Serum Determination in Women with Ovarian Cancer 148
Claudin-7 expression in human epithelial ovarian cancer 148
Differential in vitro sensitivity to patupilone versus paclitaxel in uterine and ovarian carcinosarcomas cell lines is linked to tubulin-beta-III expression. 147
Oncogenic PIK3CA gene mutations and HER2/neu gene amplifications determine the sensitivity of uterine serous carcinoma cell lines to GDC-0980, a selective inhibitor of Class I PI3 kinase and mTOR kinase (TORC1/2) 147
Revised FIGO staging for carcinoma of the vulva, cervix, andendometrium. 146
Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody 146
IN VITRO INDUCTION OF TUMOR-SPECIFIC HUMAN LYMPHOCYTE ANTIGEN CLASS I-RESTRICTED CD8 CYTOTOXIC T LYMPHOCYTES BY OVARIAN TUMOR ANTIGEN-PULSED AUTOLOGOUS DENDRITIC CELLS FROM PATIENTS WITH ADVANCED OVARIAN CANCER. 145
Hearing loss and cognitive decline in older adults: Questions and answers 145
INDUCTION OF OVARIAN TUMOR-SPECIFIC CD CYTOTOXIC T LYMPHOCYTES BY ACID-ELUTED PEPTIDE-PULSED AUTOLOGOUS DENDRITIC CELLS 144
Scaling up health knowledge at European level requires sharing integrated data: An approach for collection of database specification 144
Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy 143
Mental health and the global agenda. 143
Early stage ovarian cancer: the Italian contribution to clinical research. An update 142
Pattern of failure and value of follow-up procedures in endometrial and cervical cancer patients. 141
Replacement therapy for breast cancer survivors. A pilot study 141
Histological features of uteroplacental vessels in normal and hypertensive patients in relation to birthweight 140
Interval Cytoreduction in Ovarian Cancer 140
Trastuzumab treatment in patients with advanced or recurrent endometrial carcinoma overexpressing HER2/neu. 140
High prevalence of poor quality drug prescribing in older individuals: a nationwide report from the Italian Medicines Agency (AIFA) 140
Staging classification for cancer of the ovary, fallopian tube, and peritoneum 139
Time to face the challenge of multimorbidity. A European perspective from the joint action on chronic diseases and promoting healthy ageing across the life cycle (JA-CHRODIS) 138
New development of the FIGO staging system. 137
Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 137
INCREASED LEVELS OF INTERLEUKIN-10 AND TRANSFORMING GROWTH FACTOR-BETA IN THE PLASMA AND ASCITIC FLUID OF PATIENTS WITH ADVANCED OVARIAN CANCER. 136
Interventional tools to improve medication adherence: Review of literature 136
Carcinoma of the fallopian tube. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 135
High-grade, chemotherapy-resistant ovarian carcinomas overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody. 135
Interval debulking surgery in advanced epithelial ovarian cancer 135
Carcinoma of the corpus uteri 135
Gestational trophoblastic diseases 134
Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. 133
EXPRESSION PATTERN AND MOLECULAR FUNCTION OF TRASCRIPTION FACTOR FOXM1 (FORKHEAD BOX PROTEIN M1) IN EPITHELIAL OVARIAN CANCER CLINICAL SPECIMENS AND CELL LINES 133
Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial. 130
History of the FIGO cancer staging system 129
PHENOTYPIC AND FUNCTIONAL ANALYSIS OF TUMOR-INFILTRATING LYMPHOCYTES COMPARED WITH TUMOR-ASSOCIATED LYMPHOCYTES FROM ASCITIC FLUID AND PERIPHERAL BLOOD LYMPHOCYTES IN PATIENTS WITH ADVANCED OVARIAN CANCER. 129
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes. 128
Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas. 127
Treatment of chemotherapy-resistant human ovarian cancer xenografts in C.B-17/SCID mice by intraperitoneal administrationof Clostridium perfringens enterotoxin. 127
Totale 17.967
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.057
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.057
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.537 124 236 13 71 11 106 77 88 77 292 123 319
2022/20231.190 240 30 50 69 83 343 10 94 153 11 52 55
2023/20241.512 78 35 145 108 82 358 49 60 330 57 20 190
2024/20252.699 19 31 10 379 308 265 188 77 264 165 622 371
2025/20267.101 674 835 421 1.007 610 393 884 199 331 463 1.219 65
2026/2027103 103 0 0 0 0 0 0 0 0 0 0 0
Totale 27.584